Outlook Therapeutics, Inc. SEC filings OTLK

Outlook Therapeutics, Inc. has 833 filings in SEC EDGAR's recent list, going back to Aug 10, 2015. Its latest annual report, Form ARS, was filed on Jan 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 18, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (listing notice). The company's fiscal year ends on September 30.

Form Description Filed Period
10-Q Quarterly report Aug 18, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Feb 14, 2025 Dec 31, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
10-Q Quarterly report May 15, 2020 Mar 31, 2020
10-Q Quarterly report Feb 14, 2020 Dec 31, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
10-Q Quarterly report May 15, 2019 Mar 31, 2019
10-Q Quarterly report Feb 14, 2019 Dec 31, 2018
10-Q Quarterly report Aug 14, 2018 Jun 30, 2018
10-Q Quarterly report May 15, 2018 Mar 31, 2018
10-Q Quarterly report Feb 14, 2018 Dec 31, 2017
10-Q Quarterly report Aug 14, 2017 Jun 30, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
10-Q Quarterly report Feb 14, 2017 Dec 31, 2016
10-Q Quarterly report Aug 15, 2016 Jun 30, 2016
10-Q Quarterly report Jun 27, 2016 Mar 31, 2016

Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
OTLK (Nasdaq)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
Iselin, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1649989
Former names
Oncobiologics, Inc. (until Nov 13, 2018)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.